Anti-CIAO3 monoclonal antibody

Pre-made anti-CIAO3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CIAO3/CIAO3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2624-Ab-1/ GM-Tg-hg-IP2624-Ab-2Anti-Human CIAO3 monoclonal antibodyHuman
GM-Tg-rg-IP2624-Ab-1/ GM-Tg-rg-IP2624-Ab-2Anti-Rat CIAO3 monoclonal antibodyRat
GM-Tg-mg-IP2624-Ab-1/ GM-Tg-mg-IP2624-Ab-2Anti-Mouse CIAO3 monoclonal antibodyMouse
GM-Tg-cynog-IP2624-Ab-1/ GM-Tg-cynog-IP2624-Ab-2Anti-Cynomolgus/ Rhesus macaque CIAO3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2624-Ab-1/ GM-Tg-felg-IP2624-Ab-2Anti-Feline CIAO3 monoclonal antibodyFeline
GM-Tg-cang-IP2624-Ab-1/ GM-Tg-cang-IP2624-Ab-2Anti-Canine CIAO3 monoclonal antibodyCanine
GM-Tg-bovg-IP2624-Ab-1/ GM-Tg-bovg-IP2624-Ab-2Anti-Bovine CIAO3 monoclonal antibodyBovine
GM-Tg-equg-IP2624-Ab-1/ GM-Tg-equg-IP2624-Ab-2Anti-Equine CIAO3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2624-Ab-1/ GM-Tg-hg-IP2624-Ab-2; GM-Tg-rg-IP2624-Ab-1/ GM-Tg-rg-IP2624-Ab-2;
GM-Tg-mg-IP2624-Ab-1/ GM-Tg-mg-IP2624-Ab-2; GM-Tg-cynog-IP2624-Ab-1/ GM-Tg-cynog-IP2624-Ab-2;
GM-Tg-felg-IP2624-Ab-1/ GM-Tg-felg-IP2624-Ab-2; GM-Tg-cang-IP2624-Ab-1/ GM-Tg-cang-IP2624-Ab-2;
GM-Tg-bovg-IP2624-Ab-1/ GM-Tg-bovg-IP2624-Ab-2; GM-Tg-equg-IP2624-Ab-1/ GM-Tg-equg-IP2624-Ab-2
Products NameAnti-CIAO3 monoclonal antibody
Formatmab
Target NameCIAO3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CIAO3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2624-Ag-1Recombinant multi-species CIAO3/ HPRN/ IOP1 protein
    ORF Viral VectorvGMLV000608human NARFL Lentivirus particle
    ORF Viral VectorpGMLV000750human CIAO3 Lentivirus plasmid
    ORF Viral VectorvGMLV000750human CIAO3 Lentivirus particle
    ORF Viral VectorpGMLV000608human NARFL Lentivirus plasmid


    Target information

    Target IDGM-IP2624
    Target NameCIAO3
    Gene ID64428,67563,360496,722381,490086,101087289,511837,100065271
    Gene Symbol and Synonyms9030612I22Rik,CIAO3,HPRN,IOP1,LET1L,NAR1,NARFL,PRN
    Uniprot AccessionQ9H6Q4,Q5BK18,A4FV58
    Uniprot Entry NameCIAO3_HUMAN,CIAO3_RAT,CIAO3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000103245
    Target ClassificationN/A

    The target: CIAO3, gene name: CIAO3, also named as HPRN, IOP1, LET1L, NAR1, NARFL, PRN. Predicted to enable 4 iron, 4 sulfur cluster binding activity. Involved in several processes, including iron-sulfur cluster assembly; oxygen homeostasis; and response to hypoxia. Part of CIA complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.